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Objective: To evaluate the degree of agreement between the 
primary care physician (PCP) @SM-IV) aud patient (PHQ) in 
diagnosing Major Depressive Disorder (MDD). 
Methods: Observational study ou patients with clinical diagno- 
sis of major depression After iuclusiou PCPs completed a list with 
DSM-IV criteria for MDD, aud then, independently the patients 
completed the PHQ, a self-report version of PRIME-MD with 
items identical to the symptoms used in the DSM IV (1). Other 
PHQ-modules (somatoform disease, panic, anxiety aud alcohol 
abuse) were used to iuvestigate co morbidity. 
Results: In the study 1072 patients (meau age 48,l yr, 315 
mau aud 757 women) were considered as evaluable for baseliue- 
analysis. Among them 969 pts (90%) were diagnosed with MDD 
by the physician On basis of the patieut’ s self-diaguosis (PHQ) 
668 (68%) had MDD. Gender made a siguificaut difference 
(~~0.04) in the diagnosis made by the patient: 65% of the meu 
aud 71% of the woman had a self-diaguosis of MDD. Overall 
agreement betweeu the physician’ s aud patient’ s diagnosis was 
found to be particularly low. Analysis of the differeut symptoms: 
in both DSM-IV aud PHQ the same items/symptoms are ques- 
tioned. A comparison was doue ou the agreement betweeu PCP 
aud patient for each item. Percentages of agreement (meaning 
both PCP aud patient agree ou the presence or absence of symp- 
toms) were calculated (cross-classification in 2x2 tables) together 
with the percentage of coufirmatiou by the PCP ou presence 
of symptoms ou PHQ. Agreement rauged from 44% to 97%. 
Highest agreement-scores were obtained for the symptoms de- 
pressed mood, loss of iuterest aud fatigue. Lowest agreement was 
found for weightiappetite (44% agreement) aud suicide/suicidal 
thoughts (73% agreement). It appeared that PCPs confirmed the 
presence of suicidal thiukiug in 60% of the patients preseutiug this 
symptom. Analysis of comorbidity (PHQ) showed that 385 (42%) 
patients had a somatoform disorder, gender turued out to be a 
significant risk factor (p=O.OOS) putting women at higher risk thau 
meu (0R~l.5). Of the 1072 patients, 29% had a panic disorder. 
Anxiety complaints decreased with age (p=O.O15). Finally, 16% 
were diagnosed with alcohol abuse. Young meu (piO.0001) living 
alone (p=O.O021) were particularly at risk of developiug alcoholic 
disease. Presence of auy of these comorbid disorders euhauced 
the agreement in diagnosis made by PCP (DSM-IV) aud patient 
(PHQ) of MDD. 
Conclusions: Our results further emphasized the real iuterest of 
PHQ in the assessment of both depression diagnosis aud symptom 
severity, as well as a screeuiug iustrumeut for comorbid symptoms. 
Overall agreement betweeu diagnosis by the physician @SM-IV) 
aud the patient (PHQ) was low. This was coufinned at the level of 
the differeut symptoms/items. This fiudiug strongly suggests that 
a combined assessment, doue by both physician aud patient will 
iucrease the accuracy of the diagnosis of depression 
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Patients with depressive disorder may have difficulties in sex- 
ual fuuctiouiug. However, there have beeu few clinical studies 
ou associated cerebral regions. The purpose of this study was 
to compare the cerebral regions associated with sexual arousal 
betweeu the healthy aud depressive women by tMR1 based 
ou blood-oxygenation-level-depeudeut technique. Niue healthy 
women (meau (SD) age, 40.3( 11.6)) aud seveu depressive women 
(meau (SD) age, 41.7(13X): meau (SD) scores of BDI aud 
HAMD-17, 35.6(7.1) aud 34.9(3.1), respectively) with sexually 
poteut uuderweut to fuuctioual MRI ou a 1.5T MR scamler (GE 
Signa Horizon). The tMR1 data were obtained from 7 oblique 
plaues using gradieut-echo EPI. Sexual stimulation paradigm 
begau with a 1 miuute rest aud a 4 minute stimulation by au erotic 
video film. The braiu activation maps aud their quautificatiou were 
analyzed by the statistical parametric mapping (SPM99) program. 
The munber of pixels activated by each task was used as index of 
activation, where the significance of the differences was examined 
by unpaired t-test. The regions significantly activated by erotic 
visual stimualtiou in healthy women were middle occipital gyrus, 
middle temporal gyrus, inferior froutal gyrus, iusula, hypotha- 
lamus, septal area, anterior ciugulate gyrus, parahippocampal 
gyrus, thalamus aud amygdala. The regions depressive women 
showed lower thau 50% activity compared to healthy women 
were hypothalamus (55.5% vs. 3.0%), septal area (49.6% vs. 
8.6%), parahippocampal gyrus (18.2% vs. 5.8%) aud anterior 
ciugulate gyms (23.5% vs. 11.0%). These prelimiuary results 
suggest that the activated cerebral regions associated with sex- 
ual arousal are qualitatively aud quantitatively differeut betweeu 
healthy aud depressive women In addition, these fiudiugs may 
assist in uuderstaud ueural mechanisms for sexual dysfuuctiou in 
patients with depressive disorder. Future studies should eusure that 
treatment, iucludiug phannacotherapy, may iuflueuce the affected 
regions in patients with depressive disorder. 
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